Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
Each line starts at 100 so growth is directly comparable
| Metric | GMED | KKOYY |
|---|---|---|
| Price | $76.57 | $12.91 |
| Change today | ▲ 1.28% | ▲ 0.73% |
| Market cap | $10.28B | $10.28B |
| Return, 3 months | -2.9% | +18.7% |
| Return, year to date | -12.3% | +17.6% |
| Return, 1 year | +27.3% | +24.5% |
| P/E (TTM) | 19.6 | 21.2 |
| P/B | 2.2 | 3.5 |
| P/E percentile vs own 5y | – | – |
| Dividend yield | – | 4.04% |
| Revenue growth (YoY, latest qtr) | – | – |
| Net profit growth (YoY) | – | – |
| Gross margin | – | – |
| Operating margin | – | – |
| Net margin | – | – |
| Return on equity | – | – |
| Analyst target vs. price | – | – |
| Analyst buy share | – | – |
| RSI (14) | 50 | 52 |
| 30-day volatility | 23.8% | 17.4% |
| Max drawdown, 1 year | -24.0% | -15.5% |
| Trend read | Mixed | Strong uptrend |
| Analyst consensus | – | – |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
